Marshall Wace, LLP Anika Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 10,426 shares of ANIK stock, worth $181,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,426
Previous 16,381
36.35%
Holding current value
$181,308
Previous $404,000
57.67%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ANIK
# of Institutions
111Shares Held
11.1MCall Options Held
1.8KPut Options Held
1.9K-
Trigran Investments, Inc.2.02MShares$35.2 Million4.19% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA765KShares$13.3 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY700KShares$12.2 Million3.96% of portfolio
-
Dimensional Fund Advisors LP Austin, TX657KShares$11.4 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $254M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...